FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016150260> ?p ?o ?g. }

• W3016150260 endingPage "e18343" @default.
• W3016150260 startingPage "e18343" @default.
• W3016150260 abstract "Background Youth living with HIV (YLHIV) enrolled in HIV treatment experience higher loss to follow-up, suboptimal treatment adherence, and greater HIV-related mortality compared with younger children or adults. Despite poorer health outcomes, few interventions target youth specifically. Expanding access to mobile phone technology, in low- and middle-income countries (LMICs) in particular, has increased interest in using this technology to improve health outcomes. mHealth interventions may present innovative opportunities to improve adherence and retention among YLHIV in LMICs. Objective This study aimed to test the effectiveness of a structured support group intervention, Social Media to promote Adherence and Retention in Treatment (SMART) Connections, delivered through a social media platform, on HIV treatment retention among YLHIV aged 15 to 24 years and on secondary outcomes of antiretroviral therapy (ART) adherence, HIV knowledge, and social support. Methods We conducted a parallel, unblinded randomized controlled trial. YLHIV enrolled in HIV treatment for less than 12 months were randomized in a 1:1 ratio to receive SMART Connections (intervention) or standard of care alone (control). We collected data at baseline and endline through structured interviews and medical record extraction. We also conducted in-depth interviews with subsets of intervention group participants. The primary outcome was retention in HIV treatment. We conducted a time-to-event analysis examining time retained in treatment from study enrollment to the date the participant was no longer classified as active-on-treatment. Results A total of 349 YLHIV enrolled in the study and were randomly allocated to the intervention group (n=177) or control group (n=172). Our primary analysis included data from 324 participants at endline. The probability of being retained in treatment did not differ significantly between the 2 study arms during the study. Retention was high at endline, with 75.7% (112/163) of intervention group participants and 83.4% (126/161) of control group participants active on treatment. HIV-related knowledge was significantly better in the intervention group at endline, but no statistically significant differences were found for ART adherence or social support. Intervention group participants overwhelmingly reported that the intervention was useful, that they enjoyed taking part, and that they would recommend it to other YLHIV. Conclusions Our findings of improved HIV knowledge and high acceptability are encouraging, despite a lack of measurable effect on retention. Retention was greater than anticipated in both groups, likely a result of external efforts that began partway through the study. Qualitative data indicate that the SMART Connections intervention may have contributed to retention, adherence, and social support in ways that were not captured quantitatively. Web-based delivery of support group interventions can permit people to access information and other group members privately, when convenient, and without travel. Such digital health interventions may help fill critical gaps in services available for YLHIV. Trial Registration ClinicalTrials.gov NCT03516318; https://clinicaltrials.gov/ct2/show/NCT03516318" @default.
• W3016150260 created "2020-04-17" @default.
• W3016150260 creator A5002692795 @default.
• W3016150260 creator A5003246650 @default.
• W3016150260 creator A5012468237 @default.
• W3016150260 creator A5012863186 @default.
• W3016150260 creator A5021751465 @default.
• W3016150260 creator A5051290593 @default.
• W3016150260 creator A5052406009 @default.
• W3016150260 creator A5054219965 @default.
• W3016150260 creator A5059433100 @default.
• W3016150260 creator A5086548514 @default.
• W3016150260 date "2020-06-02" @default.
• W3016150260 modified "2023-10-13" @default.
• W3016150260 title "A Social Media–Based Support Group for Youth Living With HIV in Nigeria (SMART Connections): Randomized Controlled Trial" @default.
• W3016150260 cites W1741061793 @default.
• W3016150260 cites W1904518076 @default.
• W3016150260 cites W1966378424 @default.
• W3016150260 cites W1970341406 @default.
• W3016150260 cites W1971232672 @default.
• W3016150260 cites W1988438926 @default.
• W3016150260 cites W2007598841 @default.
• W3016150260 cites W2018893294 @default.
• W3016150260 cites W2025955133 @default.
• W3016150260 cites W2062653200 @default.
• W3016150260 cites W2075079881 @default.
• W3016150260 cites W2080468258 @default.
• W3016150260 cites W2088423598 @default.
• W3016150260 cites W2097187925 @default.
• W3016150260 cites W2110356839 @default.
• W3016150260 cites W2142727159 @default.
• W3016150260 cites W2148958761 @default.
• W3016150260 cites W2153360349 @default.
• W3016150260 cites W2174500405 @default.
• W3016150260 cites W2232607448 @default.
• W3016150260 cites W2274864455 @default.
• W3016150260 cites W2336639301 @default.
• W3016150260 cites W2338432887 @default.
• W3016150260 cites W2398857614 @default.
• W3016150260 cites W2411527917 @default.
• W3016150260 cites W2440202275 @default.
• W3016150260 cites W2615648919 @default.
• W3016150260 cites W2617299840 @default.
• W3016150260 cites W2759384476 @default.
• W3016150260 cites W2767300073 @default.
• W3016150260 cites W2769261452 @default.
• W3016150260 cites W2769696265 @default.
• W3016150260 cites W2773595861 @default.
• W3016150260 cites W2775916821 @default.
• W3016150260 cites W2782224226 @default.
• W3016150260 cites W2791696751 @default.
• W3016150260 cites W2887410293 @default.
• W3016150260 cites W2899695035 @default.
• W3016150260 cites W2899770554 @default.
• W3016150260 cites W2903883167 @default.
• W3016150260 cites W2913420271 @default.
• W3016150260 cites W2949022817 @default.
• W3016150260 cites W2961973209 @default.
• W3016150260 cites W2971222296 @default.
• W3016150260 cites W2991650168 @default.
• W3016150260 cites W3190985001 @default.
• W3016150260 cites W615585483 @default.
• W3016150260 doi "https://doi.org/10.2196/18343" @default.
• W3016150260 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7298637" @default.
• W3016150260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32484444" @default.
• W3016150260 hasPublicationYear "2020" @default.
• W3016150260 type Work @default.
• W3016150260 sameAs 3016150260 @default.
• W3016150260 citedByCount "32" @default.
• W3016150260 countsByYear W30161502602020 @default.
• W3016150260 countsByYear W30161502602021 @default.
• W3016150260 countsByYear W30161502602022 @default.
• W3016150260 countsByYear W30161502602023 @default.
• W3016150260 crossrefType "journal-article" @default.
• W3016150260 hasAuthorship W3016150260A5002692795 @default.
• W3016150260 hasAuthorship W3016150260A5003246650 @default.
• W3016150260 hasAuthorship W3016150260A5012468237 @default.
• W3016150260 hasAuthorship W3016150260A5012863186 @default.
• W3016150260 hasAuthorship W3016150260A5021751465 @default.
• W3016150260 hasAuthorship W3016150260A5051290593 @default.
• W3016150260 hasAuthorship W3016150260A5052406009 @default.
• W3016150260 hasAuthorship W3016150260A5054219965 @default.
• W3016150260 hasAuthorship W3016150260A5059433100 @default.
• W3016150260 hasAuthorship W3016150260A5086548514 @default.
• W3016150260 hasBestOaLocation W30161502601 @default.
• W3016150260 hasConcept C118552586 @default.
• W3016150260 hasConcept C141071460 @default.
• W3016150260 hasConcept C15744967 @default.
• W3016150260 hasConcept C168563851 @default.
• W3016150260 hasConcept C17744445 @default.
• W3016150260 hasConcept C1862650 @default.
• W3016150260 hasConcept C199539241 @default.
• W3016150260 hasConcept C27415008 @default.
• W3016150260 hasConcept C2778087770 @default.
• W3016150260 hasConcept C2778996113 @default.
• W3016150260 hasConcept C2779363104 @default.
• W3016150260 hasConcept C2780665704 @default.
• W3016150260 hasConcept C38652104 @default.

• next